Literature DB >> 26520204

Procedural and biophysical indicators of durable pulmonary vein isolation during cryoballoon ablation of atrial fibrillation.

Arash Aryana1, Giacomo Mugnai2, Sheldon M Singh3, Deep K Pujara4, Carlo de Asmundis2, Steve K Singh4, Mark R Bowers5, Pedro Brugada2, André d'Avila6, Padraig Gearoid O'Neill5, Gian-Battista Chierchia2.   

Abstract

BACKGROUND: Limited data exist on procedural and biophysical indicators of pulmonary vein (PV) isolation durability after the cryoballoon ablation of atrial fibrillation (AF).
OBJECTIVE: The aim of this study was to investigate the procedural and biophysical characteristics associated with late PV reconnection (PVR) and durable PV isolation (PVI) after cryoablation using the currently available second-generation cryoballoon.
METHODS: Data from 435 PVs targeted in 112 consecutive patients who underwent a repeat procedure 14 ± 3 months after an index cryoablation of AF were examined.
RESULTS: Altogether, 111 PVs (25.5%) in 71 patients (63.4%) demonstrated PVR, whereas 324 PVs (74.5%) exhibited PVI. The number and duration of cryoballoon applications did not differ between PVR and PVI. However, the time to PV isolation (time to effect) was considerably shorter (39.1 ± 11.7 seconds vs 67.6 ± 19.7 seconds; P < .001), the balloon temperature at time to effect was significantly warmer (-32.1°C ± 7.8°C vs -39.4°C ± 5.8°C; P < .001), the balloon nadir temperature was slightly cooler (-48.7°C ± 4.6°C vs -47.8°C ± 2.9°C; P = .034), and the total thaw time (56.5 ± 25.4 seconds vs 34.8 ± 9.1 seconds; P < .001) and interval thaw times at 0°C (iTT0; 14.8 ± 10.9 seconds vs 7.1 ± 2.0 seconds; P < .001) and 15°C (54.2 ± 25.4 seconds vs 33.3 ± 9.1 seconds; P < .001) were notably longer with PVI than with PVR. However, only a time to effect of ≤60 seconds and an iTT0 of ≥10 seconds emerged as significant predictors of PV isolation durability. Consequently, in a multivariate model, presence of both criteria predicted <1% and their mere absence ~75% likelihood of PVR.
CONCLUSION: A time to effect of ≤60 seconds and an iTT0 of ≥10 seconds significantly predict PV isolation durability after the cryoballoon ablation of AF. If both criteria are met, the likelihood of PV reconnection may be exceedingly low.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Cryoballoon; Pulmonary vein isolation; Reconnection

Mesh:

Year:  2015        PMID: 26520204     DOI: 10.1016/j.hrthm.2015.10.033

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  27 in total

1.  Anatomic predictors of recurrence after cryoablation for atrial fibrillation: a computed tomography based composite score.

Authors:  Aditi S Vaishnav; Edris Alderwish; Kristie M Coleman; Moussa Saleh; Parth Makker; Kabir Bhasin; Neil E Bernstein; Nicholas T Skipitaris; Stavros E Mountantonakis
Journal:  J Interv Card Electrophysiol       Date:  2020-06-30       Impact factor: 1.900

2.  Ablation of atrial fibrillation: single-shot techniques poised to dominate rhythm control strategies/the future is here.

Authors:  Antonis S Manolis
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

3.  Catheter ablation or surgery to eliminate longstanding persistent atrial fibrillation.

Authors:  Rajan L Shah; Junaid A B Zaman; Sanjiv M Narayan
Journal:  Int J Cardiol       Date:  2019-12-27       Impact factor: 4.164

4.  Thermodynamic properties of atrial fibrillation cryoablation: a model-based approach to improve knowledge on energy delivery.

Authors:  Valter Giaretto; Andrea Ballatore; Claudio Passerone; Paolo Desalvo; Mario Matta; Andrea Saglietto; Mario De Salve; Fiorenzo Gaita; Bruno Panella; Matteo Anselmino
Journal:  J R Soc Interface       Date:  2019-09-18       Impact factor: 4.118

5.  Earliest pulmonary vein potential-guided cryoballoon ablation for atrial fibrillation.

Authors:  Yoshiaki Mizutani; Masaaki Kanashiro; Yuichiro Makino; Akinori Satake; Wataru Suzuki; Masanari Kurobe; Kouji Mizutani; Hitoshi Ichimiya; Yasuhiro Uchida; Junji Watanabe; Satoshi Ichimiya; Yasuya Inden; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2019-07-11       Impact factor: 2.037

6.  Increased rate of observed real-time pulmonary vein isolation with third-generation short-tip cryoballoon.

Authors:  Alexander Pott; Kerstin Petscher; Marvin Messemer; Wolfgang Rottbauer; Tillman Dahme
Journal:  J Interv Card Electrophysiol       Date:  2016-07-23       Impact factor: 1.900

Review 7.  Catheter ablation for atrial fibrillation: current indications and evolving technologies.

Authors:  Ramanathan Parameswaran; Ahmed M Al-Kaisey; Jonathan M Kalman
Journal:  Nat Rev Cardiol       Date:  2020-10-13       Impact factor: 32.419

8.  "Clinical Impact of the Cryoballoon Temperature and Occlusion Status on the Success of Pulmonary Vein Isolation".

Authors:  Takuro Nishimura; Kaoru Okishige; Yasuteru Yamauchi; Hideshi Aoyagi; Naruhiko Ito; Yusuke Tsuchiya; Takatoshi Shigeta; Rena Nakamura; Mitsutoshi Asano; Mitsumi Yamashita; Tomofumi Nakamura; Hidetoshi Suzuki; Tsukasa Shimura; Manabu Kurabayashi; Takehiko Keida; Tetsuo Sasano; Kenzo Hirao
Journal:  J Atr Fibrillation       Date:  2018-08-31

9.  Cryoballoon-to-Pulmonary Vein Occlusion Assessment via Capnography Technique: Where Does Occlusion Testing by End-Tidal CO2 Measurement "Fit" as a Predictor of Long-Term Efficacy?

Authors:  Robert A Pickett; Kimberly Owens; Penny Landis; Rahmani Sara; Hae W Lim
Journal:  J Atr Fibrillation       Date:  2018-06-30

10.  Left atrial posterior wall isolation in conjunction with pulmonary vein isolation using cryoballoon for treatment of persistent atrial fibrillation (PIVoTAL): study rationale and design.

Authors:  Arash Aryana; Deep K Pujara; Shelley L Allen; James H Baker; Martin A Espinosa; Eric F Buch; Uma Srivatsa; Ethan Ellis; Kevin Makati; Marcin Kowalski; Sung Lee; Thomas Tadros; Tina Baykaner; Amin Al-Ahmad; André d'Avila; Luigi Di Biase; Kaoru Okishige; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2020-10-03       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.